AmCham EU and Junior Achievement Europe (JA Europe) are delighted to announce that AMIRA Meditech, a Bulgarian start-up, is the winner of the AmCham EU Youth Entrepreneurship Award 2023. Following the previous three editions, this year was again dedicated to women entrepreneurs. Natalia Konova, Chief Executive Officer and Co-founder captivated the jury with her dedication to fighting antimicrobial resistance and optimise antibiotic prescriptions in hospitals.
Bulgarian start-up AMIRA Meditech wins AmCham EU Youth Entrepreneurship Award 2023
AmCham EU and Junior Achievement Europe (JA Europe) are delighted to announce that AMIRA Meditech, a Bulgarian start-up, is the winner of the AmCham EU Youth Entrepreneurship Award 2023. Following the previous three editions, this year was again dedicated to women entrepreneurs. Natalia Konova, Chief Executive Officer and Co-founder captivated the jury with her dedication to fighting antimicrobial resistance and optimise antibiotic prescriptions in hospitals.
To fight antimicrobial resistance, AMIRA has developed a software solution to optimise antibiotic prescriptions in hospitals. By monitoring and controlling antibiotic usage, AMIRA helps doctors save time and decreases hospitals' resources. Through one-of-a-kind prediction models and more quickly adapting to the guidelines for treating infections, AMIRA seeks to preserve the effectiveness of antibiotics and save millions of lives. The algorithm is based on latest European and national guidelines for treating infections, as well as the legal documents of the antibiotics and each hospital's unique antibiotic resistance.
Chief Executive Officer and Co-founder Natalia Konova is a clinical pharmacologist at the Alexandrovska Hospital in Sofia, Bulgaria. She is also currently undertaking a PhD in improving the effectiveness and safety of antibiotics in hospital settings from Sofia’s Medical University’s Department of Pharmacology and Toxicology.
The distinguished jury was composed of Kelly Adams-Smith, Deputy Chief of Mission, US Mission to the EU; Daniel Calleja Crespo, Director-General, Legal Services, European Commission; Susan Danger, CEO of AmCham EU; Chris Delaney, President EMEA, Goodyear Europe ; and Eva Maydell, Member of the European Parliament. The jury had the difficult task of choosing a winner amongst three Junior Achievement Europe alumnae: Alexandra Dimitriadou, CEO and Co-founder of MammoCheck from Cyprus; Natalia Konova, CEO and Co-founder of AMIRA Meditech from Bulgaria; and Alexia Vasilaki, Co-founder and Chief Technology Officer of Drug n Drop from Greece.
Upon receiving the prize of 10,000 Euros and the executive mentorship, Natalia said that 'the funding will allow the start-up to raise the issue of antimicrobial resistance amongst healthcare professionals and the general public, while the mentorship will help us grow and support patients across Europe.'
Susan Danger, CEO, AmCham EU, said: 'I am proud to continue the tradition of supporting emerging women leaders in business. Natalia Konova's story shows how much you learn by starting your own business, an important reminder as we celebrate the European Year of Skills. Entrepreneurship is the basis for driving innovation and creativity and spurring new businesses in a competitive world.'
Salvatore Nigro, CEO, JA Europe, said that ‘It is truly remarkable and significant that all three finalists this year are tackling some of the most pressing issues faced by our healthcare systems, and contribute to building a vibrant start-up ecosystem in Europe!’
The AmCham EU Youth Entrepreneurship Award was launched in 2013 to recognise young people who have chosen to become entrepreneurs and to foster entrepreneurship in Europe. The initiative is supported by AmCham EU's Executive Council and organised in collaboration with JA Europe. The winner is presented with a monetary prize toward their start-up and will receive mentorship from top European CEOs of AmCham EU member companies. AmCham EU also makes a contribution to the three local JA Europe organisations, recognising their contributions to fostering entrepreneurship at local level.
+++
About AmCham EU
AmCham EU speaks for American companies committed to Europe on trade, investment and competitiveness issues. It aims to ensure a growth-orientated business and investment
Related items
:focal())
News
14 Jan 2026
Irish-made AI
Developing advanced artificial intelligence (AI) capabilities is central to Europe’s digital ambitions. With a new €175 million investment, Workday is reinforcing this priority by establishing an AI Centre of Excellence in Dublin. Building on its long-standing research and development presence, the company will expand product development and create more than 200 specialised roles. Workday is also deepening its commitment to skills, partnering with national training networks and universities to equip employees with cutting-edge AI expertise. Through these collaborations, Workday is helping to drive innovation, strengthen Europe’s digital competitiveness and support the next generation of AI talent. Discover more on Invested in Europe.
:focal())
News
9 Jan 2026
Council vote clears way for landmark EU-Mercosur free trade agreement
EU Member States’ decision to approve the EU-Mercosur free trade agreement is a major victory for the EU’s free trade agenda. For companies in the EU, the agreement promises to support deeper integration of value chains and facilitate access to a market of 284 million consumers. This will contribute to more resilient and diversified supply chains, including access to critical raw materials essential for the EU’s economic security and industrial growth.
AmCham EU praises the European Commission for its work with Member States to ensure the deal benefits all sectors of the EU economy. By concluding Mercosur’s first trade agreement with a major global partner, the EU demonstrates its commitment to open and rules-based trade. The European Parliament must now approve the agreement without delay, so that – after 25 years of negotiations – businesses and citizens can start benefiting from this deal.
Reacting to the news, Malte Lohan, CEO, AmCham EU, stressed the importance of the agreement: ‘The Council’s decision is a timely one. In today’s world, the EU needs to boost its economic competitiveness and maintain its free trade leadership. The EU-Mercosur agreement ticks both boxes’.
‘The business case is clear; the geopolitical case is clear. It is now the Parliament’s job to see the agreement across the finish line’, he added.
:focal())
News
22 Dec 2025
No further delays: the EU-Mercosur FTA is vital for a stronger Europe
The European Council’s decision to postpone its vote on concluding the EU-Mercosur free trade agreement (FTA) is a missed strategic opportunity that threatens the EU’s credibility as a reliable partner. After more than 20 years of negotiations, the EU is once again delaying one of its most ambitious and strategic trade agreements.
The EU-Mercosur FTA’s economic benefits are clear. At a time when strengthening competitiveness, economic growth and partnerships should be paramount, the FTA provides access to a market of 284 million consumers – reducing tariff and non-tariff barriers and supporting integrated supply chains.
Beyond its economic benefits, the EU-Mercosur FTA is also an important geopolitical tool. It would anchor a long-term strategic partnership with a key region and reinforce the EU’s role as a credible advocate of rules-based trade. Amid heightened geopolitical rivalry, postponement weakens the EU’s standing and its ability to conclude ambitious FTAs elsewhere.
The EU cannot afford further delays. The EU-Mercosur FTA is vital for the region’s competitiveness, resilience and global credibility. The European Council must promptly return to this file and conclude this FTA in January.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.